SOTIO to Present at the LifeSci Partners Summer Symposium

NEXT STORY
Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results
PREV STORY
AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

DURHAM, N.C., May 30, 2017 (GLOBE NEWSWIRE) -- GeneCentric Therapeutics, Inc., a precision medicine ...

author_avatar
NASDAQ Market News

Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data

Positive interim analysis demonstrated proof-of-biology and proof-of-concept for BIIB067Biogen plans to advance BIIB067 to ...

author_avatar
NASDAQ Market News

BioTelemetry, Inc. to Release First Quarter 2018 Earnings Results on April 25, 2018

author_avatar
NASDAQ Market News